Inventiva (IVEVF) Other financing activities (2020 - 2022)
Inventiva (IVEVF) posted Other financing activities of -$3.6 million for Q4 2022, down 197.78% on a QoQ basis from $3.7 million in Q3 2022.
Analysis
Inventiva (IVEVF) Other financing activities (2020 - 2022) Analysis & Trends
Inventiva has reported Other financing activities for 2 years, with the latest figure at -$3.6 million in Q4 2022.
- On a quarterly basis, Other financing activities changed N/A year-over-year to -$3.6 million in Q4 2022; TTM through Dec 2022 was $9.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5.7 million, changed 0.39% from the prior year.
- Other financing activities was -$3.6 million for Q4 2022 at Inventiva, down from $3.7 million in the prior quarter.
- The five-year high for Other financing activities was $4.7 million in Q2 2020, with the low at -$3.6 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -3.62 Mn |
| Sep 22, 2022 | 3.71 Mn |
| Jun 30, 2020 | 4.69 Mn |
| Mar 31, 2020 | 4.60 Mn |